BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27375483)

  • 1. The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular Calcification.
    Albanese I; Daskalopoulou SS; Yu B; You Z; Genest J; Alsheikh-Ali A; Schwertani AG
    Front Pharmacol; 2016; 7():149. PubMed ID: 27375483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urotensin II, urotensin-related peptide, and their receptor in aortic valve stenosis.
    Khan K; Albanese I; Yu B; Shalal Y; Al-Kindi H; Alaws H; Tardif JC; Gourgas O; Cerutti M; Schwertani A
    J Thorac Cardiovasc Surg; 2021 Jan; 161(1):e1-e15. PubMed ID: 31679703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
    Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
    Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.
    Kristof AS; You Z; Han YS; Giaid A
    Peptides; 2010 Aug; 31(8):1511-6. PubMed ID: 20433884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction.
    Dubessy C; Cartier D; Lectez B; Bucharles C; Chartrel N; Montero-Hadjadje M; Bizet P; Chatenet D; Tostivint H; Scalbert E; Leprince J; Vaudry H; Jégou S; Lihrmann I
    J Neurochem; 2008 Oct; 107(2):361-74. PubMed ID: 18710417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury.
    Prosser HC; Forster ME; Richards AM; Pemberton CJ
    Peptides; 2008 May; 29(5):770-7. PubMed ID: 17900760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma.
    Le Joncour V; Guichet PO; Dembélé KP; Mutel A; Campisi D; Perzo N; Desrues L; Modzelewski R; Couraud PO; Honnorat J; Ferracci FX; Marguet F; Laquerrière A; Vera P; Bohn P; Langlois O; Morin F; Gandolfo P; Castel H
    Front Cell Dev Biol; 2021; 9():652544. PubMed ID: 33937253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased gene expression of urotensin II-related peptide in the hearts of rats with congestive heart failure.
    Nakayama T; Hirose T; Totsune K; Mori N; Maruyama Y; Maejima T; Minagawa K; Morimoto R; Asayama K; Kikuya M; Ohkubo T; Hashimoto J; Kohzuki M; Takahashi K; Imai Y
    Peptides; 2008 May; 29(5):801-8. PubMed ID: 18314225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain.
    Mori M; Fujino M
    Peptides; 2004 Oct; 25(10):1815-8. PubMed ID: 15476951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insight into the role of urotensin II-related peptide tyrosine residue in UT activation.
    Billard E; Létourneau M; Hébert TE; Chatenet D
    Biochem Pharmacol; 2017 Nov; 144():100-107. PubMed ID: 28784291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function.
    Vaudry H; Leprince J; Chatenet D; Fournier A; Lambert DG; Le Mével JC; Ohlstein EH; Schwertani A; Tostivint H; Vaudry D
    Pharmacol Rev; 2015; 67(1):214-58. PubMed ID: 25535277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urotensin II, from fish to human.
    Vaudry H; Do Rego JC; Le Mevel JC; Chatenet D; Tostivint H; Fournier A; Tonon MC; Pelletier G; Conlon JM; Leprince J
    Ann N Y Acad Sci; 2010 Jul; 1200():53-66. PubMed ID: 20633133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Orn5]URP acts as a pure antagonist of urotensinergic receptors in rat cortical astrocytes.
    Diallo M; Jarry M; Desrues L; Castel H; Chatenet D; Leprince J; Vaudry H; Tonon MC; Gandolfo P
    Peptides; 2008 May; 29(5):813-9. PubMed ID: 18082287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordant localization of functional urotensin II and urotensin II-related peptide binding sites in the rat brain: Atypical occurrence close to the fourth ventricle.
    Bucharles C; Bizet P; Arthaud S; Arabo A; Leprince J; Lefranc B; Cartier D; Anouar Y; Lihrmann I
    J Comp Neurol; 2014 Aug; 522(11):2634-49. PubMed ID: 24478001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery disease.
    Al Kindi H; Hafiane A; You Z; Albanese I; Pilote L; Genest J; Schwertani A
    Peptides; 2014 May; 55():151-7. PubMed ID: 24642358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent cardiovascular effects of homologous urotensin II (UII)-related peptide and UII in unanesthetized eels after peripheral and central injections.
    Nobata S; Donald JA; Balment RJ; Takei Y
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R437-46. PubMed ID: 21123764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain.
    Sugo T; Murakami Y; Shimomura Y; Harada M; Abe M; Ishibashi Y; Kitada C; Miyajima N; Suzuki N; Mori M; Fujino M
    Biochem Biophys Res Commun; 2003 Oct; 310(3):860-8. PubMed ID: 14550283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of Urotensin II Receptor Prevents Vascular Dysfunction.
    Kim YA; Lee DG; Yi KY; Lee BH; Jung YS
    Biomol Ther (Seoul); 2016 Sep; 24(5):523-8. PubMed ID: 27582556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blocker.
    Rakowski E; Hassan GS; Dhanak D; Ohlstein EH; Douglas SA; Giaid A
    J Mol Cell Cardiol; 2005 Nov; 39(5):785-91. PubMed ID: 16171813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.
    Chatenet D; Létourneau M; Nguyen QT; Doan ND; Dupuis J; Fournier A
    Br J Pharmacol; 2013 Feb; 168(4):807-21. PubMed ID: 22994258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.